MedSmart Group Inc.

MedSmart Group Inc.

MSGP
MedSmart Group Inc.US flagOther OTC
0.00
USD
- -
- -
31,147.00Market Cap
2004 Y
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
TTM
Revenue per Share
483.13
11.44
9.75
307.5
153.6
58.11
0.59
10.89
0.95
1.73
1.18
Basic EPS, GAAP
-3,870.76
-61.12
-24.75
-10,362.65
2,441.29
-14.3
-3,178.4
-369.56
-196.94
8.53
0.18
Free Cash Flow per Basic Share
-3,733.1
-29.98
-10.45
-757.4
-503.64
-986.44
-188.8
-168.07
-4.8
-1.15
1.9
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-11,605.42
-266.73
-140.61
-28,278.04
-15,656.65
-15,670.95
-7,164.4
-4,365.73
-411.25
-57.82
-29.2
Tangible Book Value per Share
-1,073.32
-94.82
-58.67
-16,106.42
-7,303.55
-8,168.47
-2,615.82
-1,799.93
-140.36
-13.52
-4.8
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
Operating Margin (%)
-378.88
-446.7
-149.1
-825.2
-663.97
-421.07
-35,569.36
-1,447.76
-1,299.03
-50.33
23.41
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
-1
-2
1
- -
-4
-1
-10
3
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-801.18
-534.19
-253.87
-3,369.92
1,589.41
-24.61
-535,965.44
-3,394.05
-20,823.94
493.66
15.07
Working Capital
- -
-1
-2
-4
-3
-3
-4
-4
-7
-4
-3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
-1
-2
-4
-3
-3
-3
-4
-7
-4
-3
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
-18.42
- -
- -
- -
- -
-18.8
-1.03
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Mar'14
Jun'14
Sep'14
ST Debt
2
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
1
1
Market Capitalization
2
1
- -

Working Capital

FRC

in mil. unless spec.
Mar'14
Jun'14
Sep'14
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
3
3
Payables & Accruals
1
2
2
ST Debt
2
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
16.02%
-39.19%
Free Cash Flow
- -
27.73%
48.81%
Net Income, GAAP
- -
17,592.27%
-126.86%
Sales/Revenue/Turnover
- -
832.45%
1,032.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
1
2014
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
-729.47
-216.67
74.06
- -
-196.94
2013
2.26
2.63
0.02
- -
8.53
2014
0.09
0.04
0.01
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Adel Nasser
Full Time Employees
4
Sector
Healthcare
Industry
Medical - Care Facilities
Address
1108 Kane Concourse, 206 Bay Harbor Islands FL United States of America 33154
IPO Date
Aug 30, 2005
Business
MedSmart Group Inc. (MSGP) owns and operates a professional network of MedSmart wellness centers specializing in anti-aging treatments and medical wellness services for men. The company offers testosterone replacement therapy; erectile dysfunction treatments; hormone restoration; hypothyroidism management; allergy treatments; high cholesterol and hypertension therapies; diabetes care; hair loss and hair restoration treatments; vein treatments; cryogen therapy; weight loss programs including Smart Diet and Medi-Fast; laser hair removal; physicals with on-site labs; P-shot for men; PRP and stem cell treatments; and intravenous therapy. Incorporated in 2004 and headquartered in Bay Harbor Islands, Florida, with additional references to New York operations, MedSmart Group serves customers primarily in the United States through its medical centers focused on non-invasive treatments that enhance overall health and quality of life. In July 2021, the company appointed Davinder S. Dogra as president and acquired Milanion Limited, a developer of autonomous and robotic systems for defense, security, firefighting, mining, agriculture, and commercial applications, marking a strategic pivot toward AI-driven technologies while maintaining its core wellness offerings.